![](https://ml.globenewswire.com/media/3af2713d-0edf-4aa6-b504-9347c421b57d/small/acer-png.png)
Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
NEWTON, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant …